These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

828 related items for PubMed ID: 32505910

  • 1. Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop.
    Yaqinuddin A, Kashir J.
    Med Hypotheses; 2020 Oct; 143():109906. PubMed ID: 32505910
    [Abstract] [Full Text] [Related]

  • 2. Targeting the NLRP3 Inflammasome in Severe COVID-19.
    Freeman TL, Swartz TH.
    Front Immunol; 2020 Oct; 11():1518. PubMed ID: 32655582
    [Abstract] [Full Text] [Related]

  • 3. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
    Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NAH, Alexiou A, Batiha GE.
    Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A novel cell-based assay for dynamically detecting neutrophil extracellular traps-induced lung epithelial injuries.
    Lv D, Xu Y, Cheng H, Ke Y, Zhang X, Ying K.
    Exp Cell Res; 2020 Sep 15; 394(2):112101. PubMed ID: 32474064
    [Abstract] [Full Text] [Related]

  • 6. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.
    Schönrich G, Raftery MJ, Samstag Y.
    Adv Biol Regul; 2020 Aug 15; 77():100741. PubMed ID: 32773102
    [Abstract] [Full Text] [Related]

  • 7. Severe COVID-19: NLRP3 Inflammasome Dysregulated.
    van den Berg DF, Te Velde AA.
    Front Immunol; 2020 Aug 15; 11():1580. PubMed ID: 32670297
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19.
    Shah A.
    Front Immunol; 2020 Aug 15; 11():1021. PubMed ID: 32574259
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome.
    Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, Mostyka M, Baxter-Stoltzfus A, Borczuk AC, Loda M, Cody MJ, Manne BK, Portier I, Harris ES, Petrey AC, Beswick EJ, Caulin AF, Iovino A, Abegglen LM, Weyrich AS, Rondina MT, Egeblad M, Schiffman JD, Yost CC.
    Blood; 2020 Sep 03; 136(10):1169-1179. PubMed ID: 32597954
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Inflammasome in Times of COVID-19.
    de Rivero Vaccari JC, Dietrich WD, Keane RW, de Rivero Vaccari JP.
    Front Immunol; 2020 Sep 03; 11():583373. PubMed ID: 33149733
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.